Paul Sargos, Radiation Oncologist, Head of the radiation oncology department at Bergonié Institute, shared a post on X about a recent article he and his colleagues co-authored, adding:
“Our comments about the recent PCS 9 study evaluating metastasis directed SBRT in Oligo- MCRPC is out in the The Lancet Oncology
Ongoing more contemporary PEACE 8 randomized TRIAL.”
Title: SBRT in oligometastatic castration-resistant prostate cancer
Authors: Vérane Achard, Pierre Blanchard, David Pasquier, Paul Sargos
Read the Full Article on The Lancet Oncology
More posts featuring Paul Sargos.